Beyth Y - Search Results

1

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.

Cohen I, Rosen DJ, Altaras M, Beyth Y, Shapira J, Yigael D. Cohen I, et al. Among authors: beyth y. Br J Cancer. 1994 Mar;69(3):620-1. doi: 10.1038/bjc.1994.116. Br J Cancer. 1994. PMID: 8123501 Free PMC article. Clinical Trial. No abstract available.

2

Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?

Cohen I, Beyth Y, Tepper R, Figer A, Shapira J, Cordoba M, Yigael D, Altaras MM. Cohen I, et al. Among authors: beyth y. Gynecol Oncol. 1995 Jul;58(1):86-91. doi: 10.1006/gyno.1995.1188. Gynecol Oncol. 1995. PMID: 7789896 Review.

3

Postmenopausal tamoxifen treatment and endometrial pathology.

Cohen I, Altaras MM, Shapira J, Tepper R, Beyth Y. Cohen I, et al. Among authors: beyth y. Obstet Gynecol Surv. 1994 Dec;49(12):823-9. doi: 10.1097/00006254-199412000-00006. Obstet Gynecol Surv. 1994. PMID: 7885659 Review.

4

Ultrasonographic evaluation of the endometrium in postmenopausal tamoxifen-treated patients.

Cohen I, Altaras MM, Beyth Y. Cohen I, et al. Among authors: beyth y. Am J Obstet Gynecol. 1995 Mar;172(3):1067-8. doi: 10.1016/0002-9378(95)90062-4. Am J Obstet Gynecol. 1995. PMID: 7892861 No abstract available.

5

Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen.

Tepper R, Cohen I, Altaras M, Shapira J, Cordoba M, Dror Y, Beyth Y. Tepper R, et al. Among authors: beyth y. J Ultrasound Med. 1994 Aug;13(8):635-40. doi: 10.7863/jum.1994.13.8.635. J Ultrasound Med. 1994. PMID: 7933033 Clinical Trial.

6

Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies.

Cohen I, Tepper R, Rosen DJ, Shapira J, Cordoba M, Dror Y, Altaras M, Beyth Y. Cohen I, et al. Among authors: beyth y. Gynecol Oncol. 1994 Oct;55(1):138-43. doi: 10.1006/gyno.1994.1263. Gynecol Oncol. 1994. PMID: 7959255

7

Tamoxifen and the gynaecologist.

Cohen I, Altaras MM, Tepper R, Beyth Y. Cohen I, et al. Among authors: beyth y. Br J Obstet Gynaecol. 1994 Jul;101(7):646-7. Br J Obstet Gynaecol. 1994. PMID: 8043551 No abstract available.

8

Gynecologic tumors in tamoxifen-treated women with breast cancer.

Cohen I, Altaras MM, Beyth Y. Cohen I, et al. Among authors: beyth y. Obstet Gynecol. 1994 Jan;83(1):158-9. Obstet Gynecol. 1994. PMID: 8272299 No abstract available.

9

Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.

Cohen I, Rosen DJ, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y. Cohen I, et al. Among authors: beyth y. Gynecol Oncol. 1994 Feb;52(2):185-90. doi: 10.1006/gyno.1994.1029. Gynecol Oncol. 1994. PMID: 8314137 Clinical Trial.

10

Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer.

Cohen I, Rosen DJ, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D, Beyth Y. Cohen I, et al. Among authors: beyth y. Br J Obstet Gynaecol. 1993 Jun;100(6):567-70. doi: 10.1111/j.1471-0528.1993.tb15310.x. Br J Obstet Gynaecol. 1993. PMID: 8334093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters